Neuroinflammation in Alzheimer's disease: Current evidence and future directions - PubMed (original) (raw)
Review
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al. Alzheimers Dement. 2016 Jun.
Abstract
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results. It is clear that the "amyloid cascade hypothesis" alone cannot fully explain the neuronal damage in AD, as evidenced both by autopsy and imaging studies. Neuroinflammation plays a significant role in neurodegenerative diseases, whereas the debate is ongoing about its precise role, whether it is protective or harmful. In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease progression. We focus on neuroinflammation in AD, especially in the earliest stages, a vicious cycle of glial priming, release of pro-inflammatory factors, and neuronal damage. We review the evidence from imaging studies, regarding the temporal relationship between amyloid deposition and neuroinflammation, the influence of systemic inflammation on glial activation, both in acute and chronic stimulation and the relevance of inflammation as a diagnostic and therapeutic target.
Keywords: Alzheimer's; Microglia; Neurodegeneration; Neuroinflammation; PET; Systemic inflammation.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
- Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer's-like Amyloidosis.
Wilson EN, Do Carmo S, Iulita MF, Hall H, Austin GL, Jia DT, Malcolm JC, Foret MK, Marks AR, Butterfield DA, Cuello AC. Wilson EN, et al. Curr Alzheimer Res. 2018;15(13):1220-1230. doi: 10.2174/1567205015666180904154446. Curr Alzheimer Res. 2018. PMID: 30182855 - Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.
Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P. Zimmer ER, et al. J Neuroinflammation. 2014 Jul 8;11:120. doi: 10.1186/1742-2094-11-120. J Neuroinflammation. 2014. PMID: 25005532 Free PMC article. Review. - Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
Jorge L, Martins R, Canário N, Xavier C, Abrunhosa A, Santana I, Castelo-Branco M. Jorge L, et al. J Alzheimers Dis. 2021;80(1):113-132. doi: 10.3233/JAD-200840. J Alzheimers Dis. 2021. PMID: 33523050 Free PMC article. - Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.
Latta CH, Brothers HM, Wilcock DM. Latta CH, et al. Neuroscience. 2015 Aug 27;302:103-11. doi: 10.1016/j.neuroscience.2014.09.061. Epub 2014 Oct 5. Neuroscience. 2015. PMID: 25286385 Free PMC article. Review. - The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR, Taylor JM, Crack PJ. Minter MR, et al. J Neurochem. 2016 Feb;136(3):457-74. doi: 10.1111/jnc.13411. Epub 2015 Nov 18. J Neurochem. 2016. PMID: 26509334 Review.
Cited by
- Neuroinflammation in comorbid depression in Alzheimer's disease: A pilot study using post-mortem brain tissue.
Lin JT, Morisaki M, Sampathkumar SA, Lau LC, Boche D, Khandaker GM, Sinclair LI. Lin JT, et al. Neurosci Appl. 2024;3:None. doi: 10.1016/j.nsa.2024.104051. Neurosci Appl. 2024. PMID: 39526037 Free PMC article. - YAP Signaling in Glia: Pivotal Roles in Neurological Development, Regeneration and Diseases.
Lin L, Yuan Y, Huang Z, Wang Y. Lin L, et al. Neurosci Bull. 2024 Nov 6. doi: 10.1007/s12264-024-01308-w. Online ahead of print. Neurosci Bull. 2024. PMID: 39503968 Review. - Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress.
Krasnovskaya O, Abramchuk D, Vaneev A, Gorelkin P, Abakumov M, Timoshenko R, Kuzmichev I, Chmelyuk N, Vadehina V, Kuanaeva R, Dubrovin E, Kolmogorov V, Beloglazkina E, Kechko O, Mitkevich V, Varshavskaya K, Salikhov S, Erofeev A. Krasnovskaya O, et al. ACS Omega. 2024 Oct 17;9(43):43376-43384. doi: 10.1021/acsomega.4c03152. eCollection 2024 Oct 29. ACS Omega. 2024. PMID: 39493999 Free PMC article. - A Map of Transcriptomic Signatures of Different Brain Areas in Alzheimer's Disease.
Ferrari RR, Fantini V, Garofalo M, Di Gerlando R, Dragoni F, Rizzo B, Spina E, Rossi M, Calatozzolo C, Profka X, Ceroni M, Guaita A, Davin A, Gagliardi S, Poloni TE. Ferrari RR, et al. Int J Mol Sci. 2024 Oct 16;25(20):11117. doi: 10.3390/ijms252011117. Int J Mol Sci. 2024. PMID: 39456899 Free PMC article. - Dietary selenium intake, hypertension and cognitive function among US adults, NHANES 2011-2014.
Liang Y, Yang X, Jin J, Huang J, Wang Z, Zuo C, Wang S, Wang Q, Zhang X. Liang Y, et al. Sci Rep. 2024 Oct 25;14(1):25346. doi: 10.1038/s41598-024-75652-2. Sci Rep. 2024. PMID: 39455607 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical